European Neuropsychopharmacology
Volume 13, Issue 5 , Pages 355-363, October 2003

Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites

Department of Neuroscience, Unit of Neuropsychopharmacology, Faculty of Medicine, University of Cádiz, Plaza Fragela 9, 11003 Cádiz, Spain

Accepted 14 January 2003.

Abstract 

This study evaluates the antinociceptive effect of several tricyclic antidepressants in four nociceptive tests which employ either thermal (hot plate and tail flick tests) or chemical (formalin and acetic acid tests) stimuli. Forced swimming test was also performed as a model of depression and an activity test was also performed. Mixed antidepressants in current clinical use: amitriptyline, imipramine and clorimipramine and their respective main secondary metabolites which preferentially inhibit noradrenaline reuptake: nortriptyline, desipramine and desmethylclorimipramine, were tested (2.5–20 mg/kg, i.p.) in mice. The results show a stronger antinociceptive effect in chemical tests induced by all the drugs, compared with thermal tests. The doses needed to produce antinociception were lower than those inducing an antidepressive effect, both effects being mutually independent. The overall results show that preferentially noradrenergic tricyclics induced an antinociceptive effect comparable with that of mixed tricyclics, indicating that noradrenaline reuptake plays an important role in tricyclic-induced antinociception.

Keywords:  Tricyclics, Antidepressants, Pain, Antinociception, Noradrenaline, Serotonin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0924-977X(03)00017-8

doi:10.1016/S0924-977X(03)00017-8

European Neuropsychopharmacology
Volume 13, Issue 5 , Pages 355-363, October 2003